Clinical Trials Sponsored by Microsoft Corporation

Total 6566 results

Denver Health and Hospital Authority
Microsoft Corporation; EMC Consulting

Completed

Chronic Care Management/Patient Relationship Management Proof of Concept

Diabetes Mellitus

United States
NHS Greater Glasgow and Clyde
University of Strathclyde; Microsoft Corporation

Not yet recruiting

Clinical Trial of 3D Telemedicine

Surgery | Telemedicine

United Kingdom
NHS Greater Glasgow and Clyde
University of Strathclyde; Microsoft Corporation

Completed

3D Telemedicine: A Clinician Feedback Study

Telemedicine | Reconstructive Surgery | 3 Dimensional

United Kingdom
MicroPort CRM

Active, not recruiting

Observational Study on Inappropriate Therapies (OSIRIS)

Inappropriate Shocks From Implanted Defibrillator | ICD Replacement or Upgrade

Netherlands, United States, France, Spain, Belgium, Switzerland, Italy, United Kingdom, Germany, Austria, Portugal
MicroPort CRM

Active, not recruiting

Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO) (APOLLO)

Heart Failure | Ventricular Arrythmia | ICD | Lead

Spain, Portugal
MicroPort CRM

Completed

Triple-site Biventricular Stimulation in the Optimization of CRT (TRIUMPH-CRT)

Heart Failure

Spain, France, Portugal, Netherlands, Germany, Italy
MicroPort CRM

Completed

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination (ISIS-ICD)

Tachycardia

Spain, United States, United Kingdom, France, Japan, Germany, Italy
MicroPort CRM

Not yet recruiting

PoSt-market Assessment on Safety and Performance of J-sHAPed xFINE Lead (SHAPE)

Bradycardia
MicroPort CRM

Recruiting

Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers (CALLIOPE)

Bradycardia | Remote Monitoring

France, Belgium, Germany, Portugal, Spain, United Kingdom, Austria, Netherlands
MicroPort CRM

Recruiting

Collection of SPOT EGMs And inTra-Cardiac Impedance for Atrio-ventricUlar and inteR-ventricular Delays optimizatioN (SATURN)

Heart Failure

France
MicroPort CRM

Completed

Safety and Electrical Performances of XFINE Leads (PERSEPOLIS)

Bradycardia

France, Italy, Spain, United Kingdom, Portugal
MicroPort CRM

Completed

Clinical and Device Functional Assessment of Real World ICD Patients (CARAT)

Arrythmia | Implantable Cardioverter Defibrillator

Spain, United Kingdom, France, Netherlands, Canada, Czechia, Germany, Italy, Switzerland, Portugal, Austria, Slovakia
MicroPort CRM

Unknown

Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector (NAVIGATOR)

Arrythmia, Implatable Cardioverter Defibrillation, Lead

Germany, Spain, France, Italy, Netherlands, Portugal
MicroPort CRM

Completed

Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System (IKONE)

Bradycardia

France
MicroPort CRM

Completed

Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography (SonR-ECHO)

Heart Failure

Canada
MicroPort CRM

Recruiting

Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices (PIANO)

Heart Failure | Sudden Cardiac Death | Cardiac Rhythm Disorder

Portugal
MicroPort CRM

Recruiting

Clinical Investigation of ENO/TEO/OTO Pacing System Under MRI Environment (CAPRI)

Bradycardia

France
MicroPort CRM

Active, not recruiting

Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy (ASTRAL-4LV)

Heart Failure | Cardiac Resynchronization Therapy

Netherlands, France, Germany, Spain, Italy, Austria, Portugal
MicroPort CRM

Unknown

Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector (FRIENDS)

Heart Failure | Ventricular Arrythmia | ICD | Lead

Spain, Italy, France, Portugal
MicroPort CRM

Completed

Registry of Sleep Apnea Monitoring and Atrial Fibrillation in Pacemaker Patients (RESPIRE)

Bradycardia

Spain
MicroPort CRM

Completed

EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients (EMERALD)

Atrial Arrhythmia

United States, Germany, Spain, Denmark, Switzerland, France, Belgium, Australia, Japan, Italy, Canada, Netherlands
MicroPort Orthopedics Inc.

Active, not recruiting

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems

Joint Disease

Canada
MicroPort Orthopedics Inc.

Enrolling by invitation

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Z Revision Femoral Stems

Joint Disease

Poland
MicroPort Orthopedics Inc.

Active, not recruiting

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems

Joint Disease

United Kingdom
MicroPort Orthopedics Inc.

Active, not recruiting

Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts (AMETHYST)

Joint Disease

Canada, United States, Belgium, Germany, United Kingdom
MicroPort Orthopedics Inc.

Withdrawn

PMCF Study for PROFEMUR® Am Femoral Components and PROCOTYL® O HA Coated Acetabular Components

Joint Disease

France
IRCCS San Raffaele
Centro Cardiologico Monzino; Regione Lombardia; Orobix Srl; Microsoft Corporation; ASST Bergamo Est and other collaborators

Recruiting

Artificial Intelligence - SARS-CoV-2 Risk Evaluation (AI-SCoRE)

Covid19

Italy
MicroPort Orthopedics Inc.

Terminated

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems

Joint Disease

Belgium
MicroPort Orthopedics Inc.

Terminated

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator Cemented Femoral Stems

Joint Disease
MicroPort Orthopedics Inc.

Terminated

Post Market Clinical Follow-up Study Protocol for PROFEMUR® Xm Femoral Stems

Joint Disease

Germany
MicroPort Orthopedics Inc.

Recruiting

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Joint Diseases

Italy
MicroPort Orthopedics Inc.

Enrolling by invitation

Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK

Knee Osteoarthritis

United States
MicroPort Orthopedics Inc.

Enrolling by invitation

Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

Joint Diseases | Osteoarthritis | Avascular Necrosis | Arthritis Knee

United States, United Kingdom
MicroPort Orthopedics Inc.

Active, not recruiting

Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur

Knee Osteoarthritis | Avascular Necrosis | Degenerative Joint Disease of Knee | Rheumatoid Arthritis of Knee | Correction of Functional Deformity | Traumatic Arthritis of Knee

United States
MicroPort Orthopedics Inc.

Enrolling by invitation

Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem

Joint Diseases

United States
MicroPort Orthopedics Inc.

Enrolling by invitation

Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular Components

Joint Disease

Germany
MicroPort Orthopedics Inc.

Active, not recruiting

Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components

Joint Disease

Canada
MicroPort Orthopedics Inc.

Active, not recruiting

Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components

Joint Disease

Canada
MicroPort Orthopedics Inc.

Active, not recruiting

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem

Joint Disease

Spain
MicroPort Orthopedics Inc.

Completed

Wright Medical Technology Metal-on-Metal 522 Post-Market Surveillance Study

Joint Pain | Osteoarthritis, Hip | Hip Osteoarthritis | Hip Disease

United States
MicroPort Orthopedics Inc.

Active, not recruiting

PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components

Joint Disease

Germany
MicroPort Orthopedics Inc.

Withdrawn

Post Market Clinical Follow-Up Study for MicroPort PROFEMUR® Preserve Classic Femoral Stem

Joint Diseases
MicroPort Orthopedics Inc.

Withdrawn

Radiostereometric Analysis (RSA) of the PROFEMUR® Preserve Classic Femoral Components (TOPAZ)

Osteoarthritis | Joint Disease

Canada
MicroPort Orthopedics Inc.

Terminated

Ceramic on Metal Total Hip Replacement System Multi-Center,Investigational Device Exemption Clinical Trial (COM)

Total Hip Replacement System

United States
MicroPort Orthopedics Inc.

Terminated

CONSERVE Plus Post-Approval Study (PAS)

Other and Unspecified Injury to Hip and Thigh

United States
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Microbot Medical, INC

Not yet recruiting

Assessment of Clin. Capabilities of LIBERTY® Endovascular Robotic System's Performance & Safety in Periph. Vasc. Interv. (ACCESS-PVI)

Peripheral Vascular Interventions
MicroPort NeuroTech Co., Ltd.

Recruiting

Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE

Brain Diseases | Aneurysm | Intracranial Aneurysm

China
MicroPort NeuroTech Co., Ltd.

Recruiting

A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX

Brain Diseases | Vertebral Artery Stenosis | Vertebral Artery Thrombosis

China
MicroPort NeuroTech Co., Ltd.

Recruiting

PARAT PLUS (The Tubridge Plus For The Treatment Of Wide-Necked Intracranial Aneurysms)

Intracranial Aneurysm

China

Clinical Trials Sponsored by Microsoft Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations